Background Neutropenic sepsis (NS) is a common and predictable complication of bone
marrow disorders and cytotoxic chemotherapy, with an estimated incidence of 70–100 …

Background Neutropenic sepsis (NS) is defined by the National Institute for Health and Care
Excellence (NICE) as a temperature of greater than 38 C, with a neutrophil count of less than …

Sepsis is a major cause of mortality during the neutropenic phase after intensive cytotoxic
therapies for malignancies. Improved management of sepsis during neutropenia may …

Sepsis is a leading cause of mortality in neutropenic cancer patients. Early initiation of
effective causative therapy as well as intensive adjunctive therapy is mandatory to improve …

Neutropenic Sepsis (NS) is a well recognised treatment complication, typically occurring 7-
10 days following cancer cytotoxic chemotherapy. Colleagues in acute medicine will be only …

Sepsis and septic shock are major causes of mortality during chemotherapy-induced
neutropenia for malignancies requiring urgent treatment. Thus, awareness of the presenting …

Neutropenic sepsis is a life-threatening condition with mortality rates reported to range
between 2 and 21% in adults. It can occur following chemotherapy treatment, due to disease …

Background: Sepsis is a leading cause of mortality in patients with neutropenia; however,
data on whether neutropenic sepsis is associated with distinct clinical characteristics and …

Guidelines are recommendations for the care of individuals in specific clinical conditions or
circumstances-and these can include prevention and self-care through to primary and …

Dear Editor, Neutropenic cancer patients are at high risk of sepsis [1]. The delay and
adequacy of antimicrobial treatment are likely to influence the outcomes of such patients …